Immediate Impact
1 by Nobel laureates 1 from Science/Nature 62 standout
Citing Papers
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
Cystic Fibrosis
2023 Standout
Works of Guy‐André Loeuille being referenced
Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
1998
Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guy‐André Loeuille | 126 | 46 | 21 | 65 | 56 | 17 | 252 | |
| Justin B. Usery | 52 | 26 | 45 | 52 | 17 | 19 | 275 | |
| John Iazzetta | 22 | 44 | 28 | 18 | 82 | 23 | 251 | |
| Ramesh Srinivasan | 70 | 31 | 51 | 44 | 26 | 26 | 292 | |
| Bryan Lizza | 35 | 4 | 9 | 100 | 30 | 25 | 291 | |
| van der Linden | 47 | 13 | 9 | 39 | 63 | 14 | 284 | |
| Evren Şentürk | 84 | 3 | 13 | 36 | 6 | 27 | 284 | |
| Gregor P.M. Mannes | 219 | 4 | 13 | 48 | 18 | 10 | 297 | |
| Yehuda Baumoehl | 46 | 4 | 2 | 47 | 9 | 16 | 288 | |
| Nicole Werner | 30 | 14 | 27 | 54 | 21 | 12 | 194 | |
| Hafeez Abiola Afolabi | 23 | 15 | 3 | 15 | 12 | 26 | 207 |
All Works
Loading papers...